Wu et al. revealed that patients who presented with quick chemoresistance had an increased level of plasma cholesterol and their tumor tissue had enhanced ABCG2 expression in lung adenocarcinoma [32]. This evidence concerns the gene ABCG2 and lung adenocarcinoma.